BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Liver fibrosis
1
He-He-Shu-Yang formula alleviates liver fibrosis by inhibiting hepatic stellate cell activation in vivo and in vitro
12/26/2025 10:27:30 AM | Browse: 18 | Download: 81
2
Saffron and Calculus bovis combination exerts anti-hepatic fibrotic effect in liver fibrosis rats via the mitogen-activated protein kinases pathway
12/19/2025 10:39:43 AM | Browse: 20 | Download: 77
3
Advances in endoscopic ultrasound-guided shear wave elastography: A comprehensive review of its clinical applications
12/10/2025 7:48:07 AM | Browse: 20 | Download: 78
4
Levodopa and the dopamine receptor D1-Hippo/yes-associated protein axis: A novel therapeutic avenue for liver fibrosis
12/10/2025 7:48:07 AM | Browse: 23 | Download: 49
5
Non-invasive blood biomarkers for assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease
11/27/2025 7:53:54 AM | Browse: 8 | Download: 54
6
Real-world performance of transient elastography in assessing advanced fibrosis in Chinese patients with primary biliary cholangitis
11/6/2025 8:56:33 AM | Browse: 40 | Download: 148
7
Gray zone and the need for expansion in chronic hepatitis B: From theory to clinical practice
10/27/2025 10:57:50 AM | Browse: 130 | Download: 144
8
Nanoparticle-based systems for liver therapy: Overcoming fibrosis and enhancing drug efficacy
10/27/2025 10:57:49 AM | Browse: 102 | Download: 137
9
Revitalizing liver health: Human placental extract shows promise in chronic liver disease management
10/11/2025 9:30:02 AM | Browse: 35 | Download: 99
10
Albumin-bilirubin score reflects the extent of liver fibrosis in chronic hepatitis C patients treated with direct-acting antivirals
9/25/2025 11:24:03 AM | Browse: 95 | Download: 146
11
Machine learning fibrosis score for pediatric metabolic dysfunction-associated steatotic liver disease: Promising but premature
9/19/2025 7:57:22 AM | Browse: 364 | Download: 178
12
Dopamine receptor D1-mediated suppression of liver fibrosis via Hippo/Yes-associated protein 1 signaling in levodopa treatment
9/5/2025 6:36:19 AM | Browse: 432 | Download: 135
13
Dual therapy with vildagliptin and sacubitril/valsartan alleviates portal hypertension and inhibits soluble epoxide hydrolase in cirrhotic rats
9/1/2025 8:05:37 AM | Browse: 469 | Download: 204
14
Predictive value of core-fucosylated low-molecular-weight kininogen levels in patients with liver fibrosis: A prospective study
8/5/2025 8:25:49 AM | Browse: 63 | Download: 242
15
Poor sleep and hepatic steatosis contribute to poorer quality of life in people with human immunodeficiency virus
8/5/2025 8:25:47 AM | Browse: 62 | Download: 256
16
Utility of splenic transient elastography in assessing for the presence of portal hypertension: A review
8/4/2025 12:11:34 PM | Browse: 64 | Download: 184
17
Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives
7/25/2025 12:09:44 PM | Browse: 79 | Download: 259
18
Role of mac-2 binding protein glycosylation isomer in predicting fibrosis in patients with metabolic dysfunction-associated steatotic liver disease
7/25/2025 12:09:41 PM | Browse: 67 | Download: 280
19
FBP1 as a key regulator of focal adhesion kinase-mediated hepatic stellate cell activation: Multi-omics and experimental validation
7/24/2025 7:47:20 AM | Browse: 67 | Download: 325
20
Chronic hepatitis B with type 2 diabetes mellitus: Association between glycemic control and liver fibrosis
7/15/2025 8:26:32 AM | Browse: 72 | Download: 419
21
Multiparametric ultrasound for non-invasive assessment of liver steatosis, fibrosis and inflammation in metabolic dysfunction-associated steatotic liver disease
7/4/2025 9:23:53 AM | Browse: 76 | Download: 355
22
Dietary ω-3 polyunsaturated fatty acid intake improves skeletal muscle mass in patients with metabolic dysfunction-associated fatty liver disease: A nationwide cross-sectional study
6/26/2025 7:27:57 AM | Browse: 70 | Download: 513
23
Micro RNAs as a potential biomarker for predicting liver fibrosis severity in hepatitis C virus affected patients
6/23/2025 7:18:41 AM | Browse: 87 | Download: 534
24
Advancing the diagnosis and treatment of metabolic-associated steatotic liver disease: The transformative role of artificial intelligence
6/6/2025 9:35:52 AM | Browse: 47 | Download: 279
25
Multi-parameter magnetic resonance imaging of zebularine in liver fibrosis treatment and calcineurin/NFAT3 mechanism
5/28/2025 7:32:59 AM | Browse: 66 | Download: 382
26
Sarcopenia and frailty: An in-depth analysis of the pathophysiology and effect on liver transplant candidates
5/27/2025 7:04:49 AM | Browse: 65 | Download: 283
27
Assessing the role of Mac-2 binding protein glycosylation isomer in the management of patients with chronic hepatitis B
5/27/2025 7:04:48 AM | Browse: 73 | Download: 485
28
Quantification of Streptococcus salivarius using the digital polymerase chain reaction as a liver fibrosis marker
4/25/2025 8:23:06 AM | Browse: 82 | Download: 506
29
Psoriasis, metabolic syndrome and methotrexate: Is this association suitable for a new subcategory in steatotic liver disease?
4/25/2025 8:23:02 AM | Browse: 75 | Download: 284
30
Global trends in artificial intelligence applications in liver disease over seventeen years
3/26/2025 4:06:51 AM | Browse: 90 | Download: 679
31
Therapeutic potential of elafibranor in alcohol-associated liver disease: Insights into macrophage modulation and fibrosis reduction
3/5/2025 9:35:47 AM | Browse: 96 | Download: 347
32
Modern ultrasound techniques for diagnosing liver steatosis and fibrosis: A systematic review with a focus on biopsy comparison
2/20/2025 8:40:29 AM | Browse: 84 | Download: 406
33
Assessment of skeletal muscle alterations and circulating myokines in metabolic dysfunction-associated steatotic liver disease: A cross-sectional study
1/20/2025 7:38:55 AM | Browse: 62 | Download: 526
34
Hepatitis B virus infection and metabolic dysfunction associated steatotic liver disease: Rising pandemic with complex interaction
1/6/2025 8:47:56 AM | Browse: 85 | Download: 411
35
Hotspots and trends in stem cell therapy for liver fibrosis and cirrhosis: A bibliometric analysis
1/6/2025 8:47:54 AM | Browse: 129 | Download: 597
36
Elafibranor, a dual PPARα and PPARδ agonist, reduces alcohol-associated liver disease: Lessons from a mouse model
12/30/2024 6:47:30 AM | Browse: 69 | Download: 366
37
Red cell distribution width/platelet ratio predicts decompensation of metabolic dysfunction-associated steatotic liver disease related compensated advanced chronic liver disease
12/20/2024 3:53:49 AM | Browse: 179 | Download: 481
38
Elafibranor: A promising therapeutic approach for liver fibrosis and gut barrier dysfunction in alcohol-associated liver disease
12/20/2024 3:53:47 AM | Browse: 108 | Download: 483
39
Calculus bovis hijacks the tumor microenvironment in liver cancer cells in a multifaceted approach: A falling row of dominoes
11/29/2024 8:40:09 AM | Browse: 118 | Download: 590
40
GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis
11/29/2024 8:40:08 AM | Browse: 89 | Download: 408
41
Elafibranor alleviates alcohol-related liver fibrosis by restoring intestinal barrier function
10/31/2024 10:42:49 AM | Browse: 143 | Download: 529
42
Encapsulating taurine into liposomes: A promising therapeutic for liver fibrosis
10/23/2024 4:32:16 AM | Browse: 104 | Download: 471
43
Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes
10/17/2024 2:38:59 PM | Browse: 82 | Download: 570
44
Elafibranor: A promising treatment for alcoholic liver disease, metabolic-associated fatty liver disease, and cholestatic liver disease
10/16/2024 6:29:25 AM | Browse: 119 | Download: 429
45
Elafibranor: A promising treatment for alcohol-associated liver disease?
10/12/2024 3:43:33 AM | Browse: 123 | Download: 497
46
C23 ameliorates carbon tetrachloride-induced liver fibrosis in mice
9/23/2024 10:30:40 AM | Browse: 58 | Download: 552
47
Peroxisome proliferator-activated receptor agonists: A new hope towards the management of alcoholic liver disease
9/13/2024 3:22:17 AM | Browse: 148 | Download: 514
48
Transient elastography and diffusion-weighted magnetic resonance imaging for assessment of liver fibrosis in children with chronic hepatitis C
8/29/2024 7:51:41 AM | Browse: 116 | Download: 635
49
Mesenchymal stem cell therapy for liver fibrosis need “partner”: Results based on a meta-analysis of preclinical studies
8/27/2024 8:41:52 AM | Browse: 155 | Download: 713
50
Mesenchymal stem cells: A promising therapeutic avenue for non-alcoholic fatty liver disease
8/26/2024 5:32:18 AM | Browse: 161 | Download: 506
Write to the Help Desk
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345